Use of cyclodextrin or its complexes as a potential treatment against the 2019 novel coronavirus
Coronavirus 2 is a member of a virus family with lipid envelope that fuses with host cell through endocytosis, internalizing
Author: mariavikmon
Novel dexamethasone formulation shows efficacy and safety with once-daily use
Eric D. Donnenfeld, a consultant to Oculis reported for Ophthalmology Times on the results of a phase 2 trial: dexamethasone
Non-parenteral formulation of Remdesivir for Covid-19 treatment
Remdesivir exhibits in vitro activity against SARS-CoV-2 and was granted approval for Emergency Use. To maximize delivery to the lungs,
Coronavirus Interplay With Lipid Rafts and Autophagy Unveils Promising Therapeutic Targets.
The plasma membrane microdomain lipid rafts have been found by researchers to be involved in the replication cycle of numerous
Nitric oxide-releasing cyclodextrins as biodegradable antibacterial scaffolds: a patent evaluation of US2019343869(A1)
Introduction: Antimicrobial resistance is one of the major scourges for healthcare worldwide, therefore novel investigational approaches are needed to potentiate and
Delivering Crocetin across the Blood-Brain Barrier by Using γ-Cyclodextrin to Treat Alzheimer’s Disease
Scientific report has published a paper on γ-cyclodextrin-enabled crocetin formulation which can deliver crocetin into the brain. [1] Crocetin (CRT)
Antiviral Viroblock masks modified by CD from Wacker
Innovation in Textiles reported on the new masks of Swiss textile innovator HeiQ. The new mask, HeiQ Viroblock NPJ03 was
The Lord of the NanoRings: cyclodextrins and the battle against SARSCoV-2
Making a comparison between CDs and the unique Ring of the legendary novel of The Lord of the Rings, J.
Nobel Prize-Winning Scientist Explains Why New Study in New England Journal of Medicine May Point To Nitric Oxide as Successful Treatment For COVID-19
Cision PR Newswire has published the news from Louis Ignarro awarded the Nobel Prize in Physiology or Medicine for his
CD‐sACE2 complexes against Covid-19
Cyclodextrin‐soluble angiotensin‐converting enzyme 2 (CD‐sACE2) inclusion compounds can be useful in the treatment of SARS‐CoV‐2 infections by blocking S‐proteins .